A consensus method for the prediction of 'aggregation-prone' peptides in globular proteins.

The purpose of this work was to construct a consensus prediction algorithm of 'aggregation-prone' peptides in globular proteins, combining existing tools. This allows comparison of the different algorithms and the production of more objective and accurate results. Eleven (11) individual me...

Full description

Bibliographic Details
Main Authors: Antonios C Tsolis, Nikos C Papandreou, Vassiliki A Iconomidou, Stavros J Hamodrakas
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3542318?pdf=render
id doaj-4378e3e8ef8e413a818c5cc4477e9e92
record_format Article
spelling doaj-4378e3e8ef8e413a818c5cc4477e9e922020-11-25T00:27:13ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0181e5417510.1371/journal.pone.0054175A consensus method for the prediction of 'aggregation-prone' peptides in globular proteins.Antonios C TsolisNikos C PapandreouVassiliki A IconomidouStavros J HamodrakasThe purpose of this work was to construct a consensus prediction algorithm of 'aggregation-prone' peptides in globular proteins, combining existing tools. This allows comparison of the different algorithms and the production of more objective and accurate results. Eleven (11) individual methods are combined and produce AMYLPRED2, a publicly, freely available web tool to academic users (http://biophysics.biol.uoa.gr/AMYLPRED2), for the consensus prediction of amyloidogenic determinants/'aggregation-prone' peptides in proteins, from sequence alone. The performance of AMYLPRED2 indicates that it functions better than individual aggregation-prediction algorithms, as perhaps expected. AMYLPRED2 is a useful tool for identifying amyloid-forming regions in proteins that are associated with several conformational diseases, called amyloidoses, such as Altzheimer's, Parkinson's, prion diseases and type II diabetes. It may also be useful for understanding the properties of protein folding and misfolding and for helping to the control of protein aggregation/solubility in biotechnology (recombinant proteins forming bacterial inclusion bodies) and biotherapeutics (monoclonal antibodies and biopharmaceutical proteins).http://europepmc.org/articles/PMC3542318?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Antonios C Tsolis
Nikos C Papandreou
Vassiliki A Iconomidou
Stavros J Hamodrakas
spellingShingle Antonios C Tsolis
Nikos C Papandreou
Vassiliki A Iconomidou
Stavros J Hamodrakas
A consensus method for the prediction of 'aggregation-prone' peptides in globular proteins.
PLoS ONE
author_facet Antonios C Tsolis
Nikos C Papandreou
Vassiliki A Iconomidou
Stavros J Hamodrakas
author_sort Antonios C Tsolis
title A consensus method for the prediction of 'aggregation-prone' peptides in globular proteins.
title_short A consensus method for the prediction of 'aggregation-prone' peptides in globular proteins.
title_full A consensus method for the prediction of 'aggregation-prone' peptides in globular proteins.
title_fullStr A consensus method for the prediction of 'aggregation-prone' peptides in globular proteins.
title_full_unstemmed A consensus method for the prediction of 'aggregation-prone' peptides in globular proteins.
title_sort consensus method for the prediction of 'aggregation-prone' peptides in globular proteins.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description The purpose of this work was to construct a consensus prediction algorithm of 'aggregation-prone' peptides in globular proteins, combining existing tools. This allows comparison of the different algorithms and the production of more objective and accurate results. Eleven (11) individual methods are combined and produce AMYLPRED2, a publicly, freely available web tool to academic users (http://biophysics.biol.uoa.gr/AMYLPRED2), for the consensus prediction of amyloidogenic determinants/'aggregation-prone' peptides in proteins, from sequence alone. The performance of AMYLPRED2 indicates that it functions better than individual aggregation-prediction algorithms, as perhaps expected. AMYLPRED2 is a useful tool for identifying amyloid-forming regions in proteins that are associated with several conformational diseases, called amyloidoses, such as Altzheimer's, Parkinson's, prion diseases and type II diabetes. It may also be useful for understanding the properties of protein folding and misfolding and for helping to the control of protein aggregation/solubility in biotechnology (recombinant proteins forming bacterial inclusion bodies) and biotherapeutics (monoclonal antibodies and biopharmaceutical proteins).
url http://europepmc.org/articles/PMC3542318?pdf=render
work_keys_str_mv AT antoniosctsolis aconsensusmethodforthepredictionofaggregationpronepeptidesinglobularproteins
AT nikoscpapandreou aconsensusmethodforthepredictionofaggregationpronepeptidesinglobularproteins
AT vassilikiaiconomidou aconsensusmethodforthepredictionofaggregationpronepeptidesinglobularproteins
AT stavrosjhamodrakas aconsensusmethodforthepredictionofaggregationpronepeptidesinglobularproteins
AT antoniosctsolis consensusmethodforthepredictionofaggregationpronepeptidesinglobularproteins
AT nikoscpapandreou consensusmethodforthepredictionofaggregationpronepeptidesinglobularproteins
AT vassilikiaiconomidou consensusmethodforthepredictionofaggregationpronepeptidesinglobularproteins
AT stavrosjhamodrakas consensusmethodforthepredictionofaggregationpronepeptidesinglobularproteins
_version_ 1725341037642121216